Adhesive CapsulitisNCT07601139
Cyriax Capsular Stretching Technique and Mulligan Mobilization in Adhesive Capsulitis
A study testing Cyriax Technique and Mulligan Mobilization in people with Adhesive Capsulitis, run by Elite College of Management Sciences, Gujranwala, Pakistan at 1 site in Pakistan.
Trial summary
This study aims to evaluate the comparative effectiveness of Mulligan's mobilization versus the Cyriax capsular stretching technique for individuals suffering from adhesive capsulitis. Read more about this study
- Who is it for?
- Ages 30 to 65 years
- Conditions the study is for
- Adhesive Capsulitis
- What is being tested?
- Cyriax Technique and Mulligan Mobilization
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 sitePakistan
- Study dates
- 27 Aug 2025to 30 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- individuals with age thirty to sixty five years
- individuals with more than three months old frozen shoulder
Who cannot join
- arthritis of shoulder
- trauma
- surgery
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Elite College of Management Sciences, Gujranwala
Gujranwala, Punjab Province
About this study
Official title: Comparative Effects of Cyrixa Capsular Stretching Technique Versus Mulligan Mobilization in Adhesive Capsulitis
This study aims to evaluate the comparative effectiveness of Mulligan's mobilization versus the Cyriax capsular stretching technique for individuals suffering from adhesive capsulitis. Specifically, the research focuses on determining which approach is more successful in alleviating pain, improving shoulder range of motion (ROM), and reducing functional disability.
Read the detailed description
This randomized clinical trial, conducted in Gujranwala, involved 30 participants with adhesive capsulitis who were assigned via a lottery method into two equal groups: one receiving Cyriax capsular stretching and the other Mulligan's mobilization. Both cohorts underwent a standard baseline regimen of moist heat, TENS, and therapeutic exercises over a four-week period.
- Conditions
- Adhesive Capsulitis
- Being tested
- Cyriax Technique, Mulligan Mobilization
- Keywords
- adhesive capsulitis, cyriax techniques
- Medical subject headings
- Bursitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cyriax TechniqueOther
along with Baseline Electrotherapeutic treatment, Cyriax Stretching Technique is given to group 1 with 3 sets of 8-10 reps.
Mulligan MobilizationOther
along with Baseline Electrotherapeutic treatment, Mulligan Mobilization is given to group 1 with 3 sets of 8-10 reps.
| Study group | Role | What they receive |
|---|---|---|
| Cyriax Technique | Experimental | along with Baseline treatment, cyriax capsular stretching is given to group 1 with 3 sets of 8-10 reps. Receives: Other: Cyriax Technique |
| Mulligan Mobilization | Active comparator | along with Baseline treatment, Mulligan mobilization is given to group 1 with 3 sets of 8-10 reps. Receives: Other: Mulligan Mobilization |
What is being measured
The primary outcome is the main question the study is designed to answer.
Numeric pain rating scale
it is used to measure pain and a has a scale of 0-10 where 0 means no pain and 10 means worst possible pain
Measured: 4 weeks
Shoulder pain and disability index
it is used to measure the impact of shoulder pathology on a patient's life. A higher score indicates greater pain and functional impairment. A score of 0% represents no disability, while 100% represents maximum disability.
Measured: 4 weeks
Secondary outcomes (1)
Range of motion
Goniometer is used to measure improvement in shoulder range of motion
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 May 2026
- Study start27 Aug 2025
- Primary completion10 Apr 2026
- Study completion30 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Adhesive CapsulitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Elite College of Management Sciences, Gujranwala, Pakistan
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Imran Rafiq, PhD Rehabilitation Sciences, Study director, Elite College of Management Sciences, Gujranwala
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07601139
- Sponsor's protocol ID
- 2021-066492
- Status last verified
- May 2026
- First submitted
- 15 May 2026
- Last updated
- 22 May 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Aqdas Shahzad 1,M.,PT., MuhammadAzhar2BS., Nursing, Hassan Zafar3DPT., Muhammad A. Khan4MSc., PT., Sana Shakir5DPT. (2024). Therapeutic effects of mobilization in alleviating pain and improving shoulder mobility in adhesive capsulitis- A systematic review. Journal of Musculoskeletal Surgery and Research.
Amjad F, Asghar H. Comparative effects of gong's mobilization and mobilization with movement in patients with adhesive capsulitis: a randomized clinical trial. Sci Rep. 2025 Feb 4;15(1):4272. doi: 10.1038/s41598-025-88422-5.
PubMed 39905175Ami Makwana,N. M.(2023). The effect of cyriax soft tissue release and myofascial release on pain pressure threshold, flexibility and muscle length in idiopathic adhesive capsulitis- a comparative study. International Journal of Community Medicine and Public Health
Date A, Rahman L. Frozen shoulder: overview of clinical presentation and review of the current evidence base for management strategies. Future Sci OA. 2020 Oct 30;6(10):FSO647. doi: 10.2144/fsoa-2020-0145.
PubMed 33312703Alashkham A, Alraddadi A, Felts P, Soames R. Blood supply and vascularity of the glenoid labrum: Its clinical implications. J Orthop Surg (Hong Kong). 2017 Sep-Dec;25(3):2309499017731632. doi: 10.1177/2309499017731632.
PubMed 28920546
Study at a glance
From the registry record, last updated by the sponsor on 22 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Effects of Cyrixa Capsular Stretching Technique Versus Mulligan Mobilization in Adhesive Capsulitis
- ClinicalTrials.gov ID
- NCT07601139
- Acronym / sponsor ID
- 2021-066492
- Conditions
- Adhesive Capsulitis
- Keywords
- adhesive capsulitis, cyriax techniques
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Elite College of Management Sciences, Gujranwala, PakistanUniversity, hospital or other
- Study start
- 27 Aug 2025 (actual)
- Primary completion
- 10 Apr 2026 (actual)
- Study completion
- 30 Apr 2026 (actual)
- First posted
- 22 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the comparative effectiveness of Mulligan's mobilization versus the Cyriax capsular stretching technique for individuals suffering from adhesive capsulitis. Specifically, the research focuses on determining which approach is more successful in alleviating pain, improving shoulder range of motion (ROM), and reducing functional disability.
Detailed description
This randomized clinical trial, conducted in Gujranwala, involved 30 participants with adhesive capsulitis who were assigned via a lottery method into two equal groups: one receiving Cyriax capsular stretching and the other Mulligan's mobilization. Both cohorts underwent a standard baseline regimen of moist heat, TENS, and therapeutic exercises over a four-week period.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Cyriax Technique | Experimental | Other: Cyriax Techniquealong with Baseline treatment, cyriax capsular stretching is given to group 1 with 3 sets of 8-10 reps. |
| Mulligan Mobilization | Active comparator | Other: Mulligan Mobilizationalong with Baseline treatment, Mulligan mobilization is given to group 1 with 3 sets of 8-10 reps. |
Who may qualify
- Ages
- 30 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- individuals with age thirty to sixty five years
- individuals with more than three months old frozen shoulder
Key exclusion criteria (3 listed)
- arthritis of shoulder
- trauma
- surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cyriax Techniquealong with Baseline Electrotherapeutic treatment, Cyriax Stretching Technique is given to group 1 with 3 sets of 8-10 reps. | Other | Cyriax Technique |
| Mulligan Mobilizationalong with Baseline Electrotherapeutic treatment, Mulligan Mobilization is given to group 1 with 3 sets of 8-10 reps. | Other | Mulligan Mobilization |
Primary outcome
Numeric pain rating scale
Time frame: 4 weeks
it is used to measure pain and a has a scale of 0-10 where 0 means no pain and 10 means worst possible pain
Shoulder pain and disability index
Time frame: 4 weeks
it is used to measure the impact of shoulder pathology on a patient's life. A higher score indicates greater pain and functional impairment. A score of 0% represents no disability, while 100% represents maximum disability.
1 secondary outcome
Range of motion
Time frame: 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 May 2026.
- BackgroundAqdas Shahzad 1,M.,PT., MuhammadAzhar2BS., Nursing, Hassan Zafar3DPT., Muhammad A. Khan4MSc., PT., Sana Shakir5DPT. (2024). Therapeutic effects of mobilization in alleviating pain and improving shoulder mobility in adhesive capsulitis- A systematic review. Journal of Musculoskeletal Surgery and Research.
- Background: PubMed 39905175Amjad F, Asghar H. Comparative effects of gong's mobilization and mobilization with movement in patients with adhesive capsulitis: a randomized clinical trial. Sci Rep. 2025 Feb 4;15(1):4272. doi: 10.1038/s41598-025-88422-5.
- BackgroundAmi Makwana,N. M.(2023). The effect of cyriax soft tissue release and myofascial release on pain pressure threshold, flexibility and muscle length in idiopathic adhesive capsulitis- a comparative study. International Journal of Community Medicine and Public Health
- Background: PubMed 33312703Date A, Rahman L. Frozen shoulder: overview of clinical presentation and review of the current evidence base for management strategies. Future Sci OA. 2020 Oct 30;6(10):FSO647. doi: 10.2144/fsoa-2020-0145.
- Background: PubMed 28920546Alashkham A, Alraddadi A, Felts P, Soames R. Blood supply and vascularity of the glenoid labrum: Its clinical implications. J Orthop Surg (Hong Kong). 2017 Sep-Dec;25(3):2309499017731632. doi: 10.1177/2309499017731632.
- Individual participant dataSharing planned: No
Related trials for Adhesive Capsulitis
Not yet recruiting
Effects of Clinic Versus mHealth Application-Based Shoulder Rehabilitation in Patients With Adhesive Capsulitis
Adhesive Capsulitis
Not yet recruiting
Effect of Hormone Replacement Therapy on Physiotherapy Outcomes in Postmenopausal Women With Frozen Shoulder
Frozen Shoulder, Adhesive Capsulitis
Not yet recruiting
Effects of Posterior Capsular Stretching With and Without Dynamic Neuromuscular Stabilization Exercises in Frozen Shoulder
Frozen Shoulder
Active, not recruiting
Spencer vs. Ola Grimsby Techniques With Scapular Motor Training in Idiopathic Adhesive Capsulitis
Idiopathic Adhesive Capsulitis
Not yet recruitingPhase 4
OMT for Adhesive Capsulitis
Adhesive Capsulitis of the Shoulder, Frozen Shoulder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Imran Rafiq, PhD Rehabilitation Sciences study director
Elite College of Management Sciences, Gujranwala
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cyriax Technique and Mulligan Mobilization in people with Adhesive Capsulitis, run by Elite College of Management Sciences, Gujranwala, Pakistan at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Numeric pain rating scale (time frame: 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07601139, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2026.